Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTARES PHARMA, INC.

(ATRS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart ANTARES PHARMA, INC.
Upcoming events on ANTARES PHARMA, INC.
11/09/21 Q3 2021 Earnings Release (Projected)
03/08/22 FY 2021 Earnings Release (Projected)
05/10/22 Q1 2022 Earnings Release (Projected)
08/09/22 Interim 2022 Earnings Release (Projected)
Past events on ANTARES PHARMA, INC.
09/13/21 H.C. Wainwright Global Investment Conference
08/05/21 | 08:30am Interim 2021 Earnings Call
08/05/21 | 07:00am Interim 2021 Earnings Release
07/14/21 | 02:30pm Ladenburg Thalmann Healthcare Conference
06/22/21 | 10:40am Raymond James Human Health Innovations Conference
06/10/21 Annual General Meeting
06/02/21 | 10:00am Jefferies Healthcare Conference
05/06/21 | 08:30am Q1 2021 Earnings Call
05/06/21 | 07:00am Q1 2021 Earnings Release
05/04/21 Truist Securities Life Sciences Summit
Past dividends on ANTARES PHARMA, INC.

- No events available -

Annual results
Fiscal Period : December201620172018201920202021
Sales
M $
Released
Forecast
Spread
52,2
49,7
5,2%
54,5
55,9
-2,5%
63,6
63,0
0,84%
124
120
2,9%
150
147
1,5%
 
188
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 


 


 


 
 
31,6
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-24,1
-26,1
7,5%
-16,5
-16,6
1,1%
-16,6
-14,9
-11%
0,99
-3,74
127%
13,6
14,0
-3,0%
 
26,5
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-24,2
-26,0
6,9%
-16,7
-17,2
2,8%
-6,52
-16,8
61%
-2,03
-6,41
68%
9,92
10,8
-8,1%
 
22,7
 
Net income
M $
Released
Forecast
Spread
-24,3
-26,1
6,6%
-16,7
-17,2
2,8%
-6,52
-16,8
61%
-2,03
-6,41
68%
56,2
10,8
418%
 
18,4
 
EPS
$
Released
Forecast
Spread
-0,16
-0,17
4,5%
-0,11
-0,11
0,00%
-0,04
-0,11
63%
-0,01
-0,04
74%
0,33
0,07
408%
 
0,11
 
Announcement Date03/14/201703/13/201802/28/201903/03/202003/02/2021-
Quarterly results
Fiscal Period : December2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
Sales
M $
Released
Forecast
Spread
32,4
30,4
6,6%
40,0
35,7
12%
44,1
42,3
4,3%
42,1
39,5
6,6%
45,0
43,3
3,8%
 
49,4
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 


 


 
7,71
7,90
-2,4%
 
9,00
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
3,04
0,06
4 970%
5,85
4,27
37%
6,10
5,96
2,2%
5,39
2,59
108%
6,79
4,25
60%
 
6,98
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
2,18
-0,29
855%
5,00
4,23
18%
5,11
5,33
-4,2%
4,38
2,33
88%
5,56
3,33
67%
 
6,18
 
Net income
M $
Released
Forecast
Spread
2,18
-0,25
976%
5,00
4,27
17%
51,4
5,40
851%
3,79
2,34
62%
4,42
2,88
54%
 
4,92
 
EPS
$
Released
Forecast
Spread
0,01
-0,00
600%
0,03
0,03
15%
0,30
0,04
733%
0,02
0,01
60%
0,03
0,02
75%
 
0,03
 
Announcement Date08/06/202011/05/202003/02/202105/06/202108/05/2021-
Previous year Next Year
Upcoming sector events for ANTARES PHARMA, INC.
More events
Past sector events for ANTARES PHARMA, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise